Latin American Oncology Therapeutics Markets

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This study provides a comprehensive overview of the commercial market for lung, breast and colorectal cancer medicines responding to both cytotoxic and hormonal therapies. Researched countries are Mexico, Brazil, and Argentina. Included are competitive profiles, distribution network discussions, pricing analysis, drug pipelines, regulatory issues, major market drivers and restraints, market shares by revenue and commercial forecasts from 2005-2010.

Table of Contents

Latin American Oncology Therapeutics Markets, Market Introduction and Executive SummaryMarket Introduction and Executive SummaryExecutive SummaryMarket Introduction and HistoryCommercial Market Size and ForecastsMarket Engineering MeasurementsLatin American Oncology Therapeutics Markets, Oncology Products; Cytotoxic and Hormonal Therapies in BrazilMarket MeasurementsMarket Profile and MeasurementsMarket DriversMarket RestraintsIndustry ChallengesOncology Products for Lung CancerProduct MeasurementsProduct Pricing AnalysisProduct Distribution AnalysisDrug PipelineCompetitive MeasurementsMarket Share AnalysisOncology Products for Breast CancerProduct MeasurementsProduct Pricing AnalysisProduct Distribution AnalysisDrug PipelineCompetitive MeasurementsMarket Share AnalysisOncology Products for Colorectal CancerProduct MeasurementsProduct Pricing AnalysisProduct Distribution AnalysisDrug PipelineCompetitive MeasurementsMarket Share AnalysisLatin American Oncology Therapeutics Markets, Oncology Products; Cytotoxic and Hormonal Therapies in MexicoMarket MeasurementsMarket Profile and MeasurementsMarket DriversMarket RestraintsIndustry ChallengesOncology Products for Lung CancerProduct MeasurementsProduct Pricing AnalysisProduct Distribution AnalysisDrug PipelineCompetitive MeasurementsMarket Share AnalysisOncology Products for Breast CancerProduct MeasurementsProduct Pricing AnalysisProduct Distribution AnalysisDrug PipelineCompetitive MeasurementsMarket Share AnalysisOncology Products for Colorectal CancerProduct MeasurementsProduct Pricing AnalysisProduct Distribution AnalysisDrug PipelineCompetitive MeasurementsMarket Share AnalysisLatin American Oncology Therapeutics Markets, Oncology Products; Cytotoxic and Hormonal Therapies in ArgentinaMarket MeasurementsMarket Profile and MeasurementsMarket DriversMarket RestraintsIndustry ChallengesOncology Products for Lung CancerProduct MeasurementsProduct Pricing AnalysisProduct Distribution AnalysisDrug PipelineCompetitive MeasurementsMarket Share AnalysisOncology Products for Breast CancerProduct MeasurementsProduct Pricing AnalysisProduct Distribution AnalysisDrug PipelineCompetitive MeasurementsMarket Share AnalysisOncology Products for Colorectal CancerProduct MeasurementsProduct Pricing AnalysisProduct Distribution AnalysisDrug PipelineCompetitive MeasurementsMarket Share Analysis




Related Research

Release Date : 08-Sep-17

Region : Global

Release Date : 08-Sep-17

Region : Global

Release Date : 01-Sep-17

Region : Global

Release Date : 25-Aug-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.